ArticleOncotarget2016

The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy.

Rudolf A Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.